NeuroSense Therapeutics (NRSN) Interest Expenses (2021 - 2025)

NeuroSense Therapeutics has reported Interest Expenses for 5 years, with the latest figure at $180000.0 in Q4 2025.

• Quarterly Interest Expenses fell 97.48% year-over-year to $180000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $180000.0 (down 97.48% YoY) and the FY2025 annual result came in at $10.1 million, up 42.27% from the prior year.
• Interest Expenses slipped to $180000.0 in Q4 2025 per NRSN's latest filing, from $7.1 million in the prior quarter.
• Over five years, Interest Expenses peaked at $7.1 million in Q4 2024 and troughed at -$1.9 million in Q2 2023.
• A 5-year average of $670833.3 and a median of $1000.0 in 2021 frame the typical range for Interest Expenses.
• The widest YoY moves for Interest Expenses: up 1706.8% in 2023, down 5288.57% in 2023.
• Over 5 years, Interest Expenses stood at $201000.0 in 2021, then decreased by 26.87% to $147000.0 in 2022, then jumped by 1706.8% to $2.7 million in 2023, then jumped by 168.45% to $7.1 million in 2024, then plunged by 97.48% to $180000.0 in 2025.
• According to Business Quant data, Interest Expenses over the past three periods registered $180000.0, $7.1 million, and $2.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.